Atomoxetine is sold under the brand name Strattera. It is a medication used to treat attention deficit hyperactivity Strattera is a norepinephrine reuptake inhibitor, which means it allows the neurotransmitter norepinephrine to be available to the brain’s neurons for longer.It can take four to six weeks before Strattera reaches its maximum therapeutic effect. Once therapeutic levels have been reached, the effects of the medication last 24 hours.
It also raises the quantity of the neurotransmitter dopamine in the prefrontal cortex of the brain.disorder. It may be used alone or along with stimulants. Strattera increased the risk of suicidal, Anyone considering the use of Strattera in a child or adolescent must balance this risk with the clinical need. Patients who are started on therapy should be monitored closely for suicidality,clinical worsening, or unusual changes in behavior. STRATTERA should be used with caution in patients whose underlying medical conditions could be worsened by increases in blood pressure or heart rate such as certain patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease. It should not be used in patients with severe cardiac or vascular disorders whose condition would be expected to deteriorate if they experienced clinically important increases in blood pressure or heart rate. Pulse and blood pressure should be measured at baseline, following STRATTERA dose increases, and periodically while on therapy to detect possible clinically important increases.